- Home
- INCR vs NTRB Comparison
INCR vs NTRB Comparison
Compare INCR & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- NTRB
- Stock Information
- Founded
- INCR 1994
- NTRB 2016
- Country
- INCR Israel
- NTRB United States
- Employees
- INCR N/A
- NTRB N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- INCR Health Care
- NTRB Health Care
- Exchange
- INCR Nasdaq
- NTRB Nasdaq
- Market Cap
- INCR 84.5M
- NTRB 94.3M
- IPO Year
- INCR N/A
- NTRB N/A
- Fundamental
- Price
- INCR $1.55
- NTRB $8.14
- Analyst Decision
- INCR
- NTRB Buy
- Analyst Count
- INCR 0
- NTRB 1
- Target Price
- INCR N/A
- NTRB $13.00
- AVG Volume (30 Days)
- INCR 24.7K
- NTRB 135.2K
- Earning Date
- INCR 08-15-2025
- NTRB 09-02-2025
- Dividend Yield
- INCR N/A
- NTRB N/A
- EPS Growth
- INCR N/A
- NTRB N/A
- EPS
- INCR N/A
- NTRB N/A
- Revenue
- INCR $65,575,323.00
- NTRB $2,398,437.00
- Revenue This Year
- INCR $69.54
- NTRB $560.75
- Revenue Next Year
- INCR $41.75
- NTRB $588.39
- P/E Ratio
- INCR N/A
- NTRB N/A
- Revenue Growth
- INCR N/A
- NTRB 18.92
- 52 Week Low
- INCR $1.17
- NTRB $3.72
- 52 Week High
- INCR $2.62
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- INCR 53.16
- NTRB 51.71
- Support Level
- INCR $1.48
- NTRB $7.93
- Resistance Level
- INCR $1.64
- NTRB $11.68
- Average True Range (ATR)
- INCR 0.05
- NTRB 0.69
- MACD
- INCR 0.01
- NTRB -0.07
- Stochastic Oscillator
- INCR 57.14
- NTRB 20.96
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.